122 related articles for article (PubMed ID: 13804475)
21. A patient with metastatic breast cancer 15 years after bilateral prophylactic total mastectomy and oophorectomy.
El-Amm J; Ghanem H; Zeck J; Akin E; Siegel R
Clin Breast Cancer; 2012 Dec; 12(6):450-3. PubMed ID: 22981938
[No Abstract] [Full Text] [Related]
22. Studies with tritium-labelled hexoestrol in advanced breast cancer. Comparison of tissue accumulation of hexoestrol with response to bilateral adrenalectomy and oophorectomy.
FOLCA PJ; GLASCOCK RF; IRVINE WT
Lancet; 1961 Oct; 2(7206):796-8. PubMed ID: 13893792
[No Abstract] [Full Text] [Related]
23. Prophylactic castration in carcinoma of the breast.
ROSENBERG MF; UHLMANN EM
AMA Arch Surg; 1959 Mar; 78(3):376-9. PubMed ID: 13626342
[No Abstract] [Full Text] [Related]
24. The use of urinary estrogen estimations as a means of predicting response to oophorectomy and adrenalectomy in breast cancer.
PALMER JD; HELSTROM J
Can J Surg; 1962 Apr; 5():180-6. PubMed ID: 14483409
[No Abstract] [Full Text] [Related]
25. Prophylactic oophorectomy for breast carcinoma.
SCHAAF FC
J Abdom Surg; 1962 Jul; 4():100-2. PubMed ID: 14497869
[No Abstract] [Full Text] [Related]
26. [BILATERAL OOPHORECTOMY, RIGHT ADRENALECTOMY AND PORTAL DERIVATION OF ADRENAL HORMONES IN THE ADVANCED CANCER OF THE BREAST AND ITS METASTASIS].
VIAGGIO JA; DEDOMINICIS CF
Acad Peru Cir; 1964 Sep; 17():273-7. PubMed ID: 14324653
[No Abstract] [Full Text] [Related]
27. Chemotherapy with or without oophorectomy in high-risk premenopausal patients with operable breast cancer.
Ludwig Breast Cancer Study Group
J Clin Oncol; 1985 Aug; 3(8):1059-67. PubMed ID: 2862223
[TBL] [Abstract][Full Text] [Related]
28. Use of genetic testing and prophylactic mastectomy and oophorectomy in women with breast or ovarian cancer from families with a BRCA1 or BRCA2 mutation.
Meijers-Heijboer H; Brekelmans CT; Menke-Pluymers M; Seynaeve C; Baalbergen A; Burger C; Crepin E; van den Ouweland AW; van Geel B; Klijn JG
J Clin Oncol; 2003 May; 21(9):1675-81. PubMed ID: 12721241
[TBL] [Abstract][Full Text] [Related]
29. [Bilateral carcinoma of the breast].
Ninfo V; Pezzuoli G; Piazza M; Roviaro G
Minerva Chir; 1975 May; 30(10):592-601. PubMed ID: 167326
[TBL] [Abstract][Full Text] [Related]
30. "PROPHYLACTIC" OVARIECTOMY AND OVARIAN IRRADIATION IN BREAST CANCER.
NISSEN-MEYER R
Acta Unio Int Contra Cancrum; 1964; 20():527-30. PubMed ID: 14151979
[No Abstract] [Full Text] [Related]
31. [Renal carcinoma appearing after mastectomy and ovariectomy].
Polito M; Muzzonigro G
Acta Urol Belg; 1981 Jan; 49(1):85-9. PubMed ID: 7211622
[No Abstract] [Full Text] [Related]
32. [OOPHORECTOMY IN ADVANCED BREAST CANCER].
DE ANDRADE CF
Arq Oncol; 1963; 5():153-68. PubMed ID: 14118617
[No Abstract] [Full Text] [Related]
33. Therapeutic castration for advanced mammary cancer.
BLOCK GE; LAMPE I; VIAL AB; COLLER FA
Surgery; 1960 Jun; 47():877-84. PubMed ID: 13801525
[No Abstract] [Full Text] [Related]
34. Persistence of urinary oestrogen excretion after oophorectomy and adrenalectomy.
BULBROOK RD; GREENWOOD FC
Br Med J; 1957 Mar; 1(5020):662-6. PubMed ID: 13404266
[No Abstract] [Full Text] [Related]
35. [Indications and evaluation criteria for bilateral ovariectomy and adrenalectomy in the treatment of metastatic breast neoplasms].
Rocco B; Grossi A; Carli A
Ann Ital Chir; 1967 Dec; 43(6):963-86. PubMed ID: 5620332
[No Abstract] [Full Text] [Related]
36. An evaluation of therapeutic surgical castration in the treatment of metastatic, recurrent, and primary inoperable mammary carcinoma in women; an analysis of 191 patients.
TREVES N; FINKBEINER JA
Cancer; 1958; 11(2):421-38. PubMed ID: 13511363
[No Abstract] [Full Text] [Related]
37. SEVEN-YEAR SURVIVAL AFTER BILATERAL ADRENALECTOMY AND OOPHORECTOMY FOR CARCINOMATOSIS.
TAYLOR H
Proc R Soc Med; 1964 Aug; 57(8):676-8. PubMed ID: 14195856
[No Abstract] [Full Text] [Related]
38. Effect of mastectomy versus mastectomy plus adjuvant ovariectomy on prolactin response to TRH in breast cancer.
Ayala D; Lissoni P; Archili C; Barni S; Roveda G; Giacomelli M; Bissi A
J Biol Regul Homeost Agents; 1990; 4(4):150-2. PubMed ID: 2128988
[TBL] [Abstract][Full Text] [Related]
39. Treatment of advanced cancer of the breast with 5-fluorouracil.
Vansant JH; Payne RL; Wheeler JR
Am Surg; 1971 May; 37(5):287-9. PubMed ID: 5576598
[No Abstract] [Full Text] [Related]
40. Breast cancer risk after bilateral prophylactic oophorectomy in BRCA1 mutation carriers.
Rebbeck TR; Levin AM; Eisen A; Snyder C; Watson P; Cannon-Albright L; Isaacs C; Olopade O; Garber JE; Godwin AK; Daly MB; Narod SA; Neuhausen SL; Lynch HT; Weber BL
J Natl Cancer Inst; 1999 Sep; 91(17):1475-9. PubMed ID: 10469748
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
